Difference between revisions of "Pharm Meeting Minutes 2021.03.17"

From IHE Wiki
Jump to navigation Jump to search
Line 19: Line 19:
  
 
===Change Proposals ===
 
===Change Proposals ===
 +
 +
* Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.
  
 
Overview: [https://drive.google.com/file/d/1d4TiC2h7qRiS7oEZVDNU2soQULycZyhQ/view?usp=sharing CP Overview]
 
Overview: [https://drive.google.com/file/d/1d4TiC2h7qRiS7oEZVDNU2soQULycZyhQ/view?usp=sharing CP Overview]
Line 24: Line 26:
 
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles
 
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles
 
:* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile)
 
:* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile)
 +
** Dose and rate quantity is herited from PCC. Is it a quantity or a range.  Which unit is allowed.There is a difference with PCC definition.
 
:* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
 
:* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
 +
** Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction
 
:* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile)
 
:* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile)
 
:* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile)
 
:* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile)

Revision as of 07:19, 17 March 2021

Meeting details

Location

Session 1 Login for Teams
Session 2 Login for Teams

Minutes

Q1 13:00- 14:30 Change proposals & Medication Lists

  • Participants:
    • Leonidas Tzimis
    • Stephane Spahni
    • Jose Costa Teixeira
    • Michael Tan


Change Proposals

  • Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.

Overview: CP Overview

  • CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
  • CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
    • Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition.
  • CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
    • Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction

For information only:

  • CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
  • CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles

Medication lists

14:30- 15:00 Break

Q2 15:00- 16:30 Vaccination Topics

Participants

Work items

Logical Model

  • WHO model
  • European Model
  • Belgian Model
  • German Model
  • The IHE Pharmacy material can be found here:

https://github.com/IHE/pharm-vaccination

and

http://build.fhir.org/ig/IHE/pharm-vaccination/branches/master/StructureDefinition-ihe-pharm-vaccination.html

  • the WHO FHIR material can be found in Github.

https://github.com/who-int/svc

https://github.com/gcangioli/vaccineCertificate


Pharmacy Technical Committee

Retrieved from "http://wiki.ihe.net/index.php?title=Pharm_Meeting_Minutes_2021.03.17&oldid=124511"